However, using a mouse xenograft generated using a cell line derived from a renal cancer patient with BHD syndrome, we found that silencing of either TFEB or TFE3 was able to rescue the tumorigenic phenotype [13, 17]. The gene discussed is TFEB; the disease is renal carcinoma.